Issue · Healthcare

Healthcare (Prescription Drugs)

Every healthcare bill, vote, and legislator stance in Michigan, automatically classified by Maddy, our AI policy reader.

Total bills
27
2025-2026 Regular Session
Top supporter
Darrin Camilleri
100% support rate
Top opponent
Aric Nesbitt
0% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving prescription drugs in Michigan

Legislators moving prescription drugs in Michigan
Legislator Party Stance Support rate Votes
Darrin Camilleri
Darrin Camilleri Senate · District 4
D
Strong +
100% 3
Dayna Polehanki
Dayna Polehanki Senate · District 5
D
Strong +
100% 3
Erika Geiss
Erika Geiss Senate · District 1
D
Strong +
100% 3
Jeff Irwin
Jeff Irwin Senate · District 15
D
Strong +
100% 3
Jeremy Moss
Jeremy Moss Senate · District 7
D
Strong +
100% 3
Aric Nesbitt
Aric Nesbitt Senate · District 20
R
Strong −
0% 3
Dan Lauwers
Dan Lauwers Senate · District 25
R
Strong −
0% 3
Ed McBroom
Ed McBroom Senate · District 38
R
Strong −
0% 3
Jim Runestad
Jim Runestad Senate · District 23
R
Strong −
0% 3
Joe Bellino
Joe Bellino Senate · District 16
R
Strong −
0% 3
Showing 11–20 of 27 bills

All healthcare bills

in committee · Michigan · House Sep 9, 2025

HB 4837: Health: pharmaceuticals; ivermectin; allow over-the-counter access. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding secs. 17771 & 17771a.

This bill would allow pharmacists to sell ivermectin without a prescription in oral, tablet, or topical forms. Pharmacists and retail pharmacies would be directly affected, as they could make the drug available over-the-counter under specific conditions. Key requirements include that the drug must be manufactured under good manufacturing practices and clearly labeled with dosage instructions, contraindications, and safety information. The bill amends Michigan’s Public Health Code to create these provisions (sections 17771 and 17771a).
in committee · Michigan · House Jun 4, 2025

HB 4544: Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

HB 4544 creates Michigan's Prescription Drug Affordability Board and Stakeholder Council to review and set price limits for prescription drugs. The Board will establish upper payment limits for brand-name, generic, biologic, and biosimilar drugs, requiring manufacturers to justify price increases above the Consumer Price Index. This directly affects drug manufacturers, health insurers, pharmacy benefit managers, and patients by limiting how much they can charge for covered medications. The law aims to improve drug affordability through state oversight, with the Board required to conduct annual reviews and set rules for pricing.
Sub-Topics Prescription Drugs
passed · Michigan · Senate Apr 22, 2025

SB 107: Insurance: health insurers; coverage for immunization agents and certain laboratory tests administered and ordered by a pharmacist; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406ss.

Senate Bill 107 requires health insurance policies delivered or renewed in Michigan to provide coverage for specific services administered or ordered by pharmacists, starting January 1, 2026. This includes immunizations listed on CDC schedules, certain laboratory tests, and drugs dispensed by a pharmacist, provided these services are received at an in-network pharmacy and are within the scope of practice defined by the public health code. The bill allows insurers to apply existing utilization management, prior authorization, and cost-sharing requirements, such as deductibles or co-pays, to this coverage.
in committee · Michigan · Senate May 20, 2025

SB 317: Health: pharmaceuticals; program for the wholesale importation of pharmaceuticals from Canada; provide for. Creates new act.

Senate Bill 317 authorizes the Michigan Department of Health and Human Services (DHHS) to establish a wholesale prescription drug importation program. This program would allow for the importation of prescription drugs from regulated Canadian suppliers, aiming to reduce costs for Michigan consumers. Before implementation, the DHHS must obtain federal certification and ensure that imported drugs meet U.S. Food and Drug Administration safety standards and are expected to result in significant cost savings. The bill requires the DHHS to contract with a licensed drug wholesaler, develop a registration process for participating pharmacies and insurers, and submit annual reports on the program's operation and cost savings.
Sub-Topics Prescription Drugs
in committee · Michigan · House Jun 4, 2025

HB 4546: Insurance: health insurers; compliance with the prescription drug cost and affordability review act; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406tt. TIE BAR WITH: HB 4544'25

HB 4546 requires health insurers in Michigan providing prescription drug coverage to comply with Section 12 of the Prescription Drug Cost and Affordability Review Act. This bill directly affects health insurance companies operating in Michigan that offer prescription drug benefits. The key provision mandates these insurers to follow specific cost and affordability review requirements already established under the Review Act. The bill is tied to companion legislation (HB 4544) and is currently pending in the House Committee on Government Operations.
Sub-Topics Prescription Drugs
in committee · Michigan · House Jun 4, 2025

HB 4545: Human services: medical services; compliance with the prescription drug cost and affordability review act; require. Amends 1939 PA 280 (MCL 400.1 - 400.119b) by adding sec. 109o. TIE BAR WITH: HB 4544'25

HB 4545 requires Michigan's medical assistance program to comply with Section 12 of the Prescription Drug Cost and Affordability Review Act. This bill directly affects low-income residents enrolled in Michigan's medical assistance program by mandating adherence to state drug cost review requirements. The key provision adds Section 109o to Michigan's Social Welfare Act, making compliance with the drug cost review act a program requirement. The bill is conditional, stating it will not take effect unless companion legislation (HB 4544) is enacted into law. The bill was introduced on June 3, 2025, and referred to the Government Operations Committee.
Sub-Topics Prescription Drugs
passed · Michigan · Senate Apr 24, 2025

SB 3: Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

SB 3 creates a Prescription Drug Affordability Board to establish maximum payment limits for certain prescription drugs, including brand-name, generic, biologic, and biosimilar medications. The Board, appointed by the governor with health care expertise, will review drug costs and set these limits to improve affordability for Michigan residents. It also establishes a Prescription Drug Affordability Stakeholder Council to provide input and a fund to support the program. This law directly affects drug manufacturers, health insurers, pharmacy benefit managers, and state agencies by requiring adherence to the set payment limits.
Sub-Topics Prescription Drugs
passed · Michigan · Senate Apr 24, 2025

SB 4: Insurance: health insurers; compliance with the prescription drug cost and affordability review act; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406tt. TIE BAR WITH: SB 0003'25

Senate Bill 4 amends Michigan's insurance code to require health insurers that provide prescription drug coverage to comply with section 12 of the prescription drug cost and affordability review act. This means insurers delivering or renewing health policies in the state must adhere to specific provisions outlined in that separate act related to prescription drug costs. The bill's enactment is dependent on Senate Bill No. 3 also becoming law.
passed · Michigan · Senate Apr 24, 2025

SB 5: Human services: medical services; compliance with the prescription drug cost and affordability review act; require. Amends 1939 PA 280 (MCL 400.1 - 400.119b) by adding sec. 109o. TIE BAR WITH: SB 0003'25

Senate Bill 5 mandates that Michigan's medical assistance program, which includes Medicaid, must comply with section 12 of the "prescription drug cost and affordability review act," subject to federal law. This means the state's program for medical assistance will be required to follow specific rules related to prescription drug costs and affordability outlined in that separate act. The bill will only become effective if Senate Bill No. 3 of the 103rd Legislature is also passed into law.
Sub-Topics Prescription Drugs
passed both · Michigan · House May 19, 2026

HB 4839: Human services: medical services; requirement to prescribe generic medications; provide for. Amends 1939 PA 280 (MCL 400.1 - 400.119b) by adding sec. 109z.

HB 4839 requires Michigan's medical assistance program (like Medicaid) to cover only generic drugs when a brand-name equivalent exists, unless a doctor specifically indicates otherwise on the prescription. Doctors can override this by writing "dispense as written" or "d.a.w." on a written prescription, initialing a preprinted statement allowing substitution, or verbally specifying brand-name use. This directly affects patients enrolled in Michigan's medical assistance program and healthcare providers writing prescriptions for covered medications. The bill aims to standardize coverage toward cost-effective generic drugs while preserving physician discretion in specific cases.
Sub-Topics Prescription Drugs
Showing 11 to 20 of 27 bills